{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:06:44Z","timestamp":1789538804278,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.rpth.2026.106925","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:32:20Z","timestamp":1787927540000},"page":"106925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["ABCB1 genotype and clinically relevant bleeding risk during extended anticoagulation therapy for pulmonary embolism: a two-phase study"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7602-096X","authenticated-orcid":false,"given":"Zhu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haobo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingzhang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhi","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuangxun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Duo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbo","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2026.106925_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMcp2116489","article-title":"Pulmonary embolism","volume":"387","author":"Kahn","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106925_bib2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.chest.2018.10.040","article-title":"Trends in hospitalization and in-hospital mortality from VTE, 2007 to 2016, in China","volume":"155","author":"Zhang","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2026.106925_bib3","article-title":"Epidemiology of pulmonary embolism in China, 2021: a nationwide hospital-based study","volume":"54","author":"Zhen","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.rpth.2026.106925_bib4","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa2416112","article-title":"Extended reduced-dose apixaban for cancer-associated venous thromboembolism","volume":"392","author":"Mah\u00e9","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106925_bib5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/bjh.16275","volume":"188","author":"Bradbury","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2026.106925_bib6","doi-asserted-by":"crossref","first-page":"JC10","DOI":"10.7326\/ANNALS-25-04963-JC","article-title":"In provoked VTE with \u22651 enduring risk factor, extending anticoagulation with apixaban reduced symptomatic recurrent VTE at 12 mo","volume":"179","author":"Dunn","year":"2026","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2026.106925_bib7","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMoa2509426","article-title":"Apixaban for extended treatment of provoked venous thromboembolism","volume":"393","author":"Piazza","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106925_bib8","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106925_bib9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMoa2510703","article-title":"Bleeding risk with apixaban vs. rivaroxaban in acute venous thromboembolism","volume":"394","author":"Castellucci","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106925_bib10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/a-2642-0241","article-title":"Performance of bleeding risk scores for major bleeding in anticoagulated patients with pulmonary embolism: insights from the CURES Registry-2","volume":"126","author":"Tao","year":"2026","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106925_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02963-2020","article-title":"Trends in risk stratification, in-hospital management and mortality of patients with acute pulmonary embolism: an analysis from the China pUlmonary thromboembolism REgistry Study (CURES)","volume":"58","author":"Zhai","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rpth.2026.106925_bib12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0040-1718729","article-title":"The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease","volume":"121","author":"Kim","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106925_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehag246","article-title":"Direct oral anticoagulants vs warfarin in Asian vs non-Asian patients with atrial fibrillation: a patient-level meta-analysis from COMBINE AF","author":"Chao","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2026.106925_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archinte.159.5.457","article-title":"Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism","volume":"159","author":"Kuijer","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rpth.2026.106925_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1160\/TH08-03-0193","article-title":"Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry","volume":"100","author":"Ru\u00edz-Gim\u00e9nez","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106925_bib16","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1183\/13993003.00280-2016","article-title":"Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment","volume":"48","author":"Klok","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rpth.2026.106925_bib17","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.chest.2021.06.048","article-title":"An original risk score to predict early major bleeding in acute pulmonary embolism","volume":"160","author":"Chopard","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.rpth.2026.106925_bib18","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurheartj\/ehac776","article-title":"Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score","volume":"44","author":"de Winter","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rpth.2026.106925_bib19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41397-018-0037-1","article-title":"Frequency of vitamin K oxidoreductase complex subunit-1 (VKORC1) polymorphisms and warfarin dose management in patients with venous thromboembolism","volume":"18","author":"Kabalak","year":"2018","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.rpth.2026.106925_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2016.8662","article-title":"Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack","volume":"316","author":"Wang","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.rpth.2026.106925_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.040698","article-title":"Association of genetic variants with rivaroxaban pharmacokinetics and pharmacodynamics and hemorrhage risk factors in patients with venous thromboembolism","volume":"14","author":"Li","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.rpth.2026.106925_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1263","article-title":"Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation: a multicentre prospective cohort study","volume":"13","author":"Xiang","year":"2023","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.rpth.2026.106925_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12916-023-02844-4","article-title":"Genome-wide association analyses identified novel susceptibility loci for pulmonary embolism among Han Chinese population","volume":"21","author":"Zhang","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.rpth.2026.106925_bib24","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2026.106925_bib25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/cpt.2714","article-title":"Personalizing direct oral anticoagulant therapy for a diverse population: role of race, kidney function, drug interactions, and pharmacogenetics","volume":"113","author":"Thompson","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.rpth.2026.106925_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/bdd.2327","article-title":"Effect of ABCB1 gene variants on rivaroxaban pharmacokinetic and hemorrhage events occurring in patients with non-valvular atrial fibrillation","volume":"43","author":"Zhang","year":"2022","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.rpth.2026.106925_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rpth.2026.106925_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102357","article-title":"Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in CYP2C19 loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trial","volume":"67","author":"Wang","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.rpth.2026.106925_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1007113","article-title":"Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients","volume":"13","author":"Campos-Staffico","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.rpth.2026.106925_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2026.1792186","article-title":"Pharmacogenomics of direct oral anticoagulants: a systematic review and meta-analysis","volume":"13","author":"Chai","year":"2026","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.rpth.2026.106925_bib31","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/cpt.2316","article-title":"Pharmacogenetics of bleeding and thromboembolic events in direct oral anticoagulant users","volume":"110","author":"L\u00e4hteenm\u00e4ki","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.rpth.2026.106925_bib32","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3389\/fphar.2016.00494","article-title":"Rivaroxaban-induced hemorrhage associated with ABCB1 genetic defect","volume":"7","author":"Ing Lorenzini","year":"2016","journal-title":"Front Pharmacol"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926035831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037926035831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:57:36Z","timestamp":1789538256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037926035831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2475037926035831"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106925","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ABCB1 genotype and clinically relevant bleeding risk during extended anticoagulation therapy for pulmonary embolism: a two-phase study","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2026.106925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"106925"}}